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Erythritol is the preferential carbon source for most brucellae, a group of facultative
intracellular bacteria that cause a worldwide zoonosis. Since this polyol is abundant in
genital organs of ruminants and swine, it is widely accepted that erythritol accounts
at least in part for the characteristic genital tropism of brucellae. Nevertheless, proof
of erythritol availability and essentiality during Brucella intracellular multiplication has
remained elusive. To investigate this relationship, we compared 1eryH (erythritol-
sensitive and thus predicted to be attenuated if erythritol is present), 1eryA (erythritol-
tolerant but showing reduced growth if erythritol is a crucial nutrient) and wild type
B. abortus in various infection models. This reporting system indicated that erythritol was
available but not required for B. abortus multiplication in bovine trophoblasts. However,
mice and humans have been considered to lack erythritol, and we found that it was
available but not required for B. abortus multiplication in human and murine trophoblastic
and macrophage-like cells, and in mouse spleen and conceptus (fetus, placenta and
envelopes). Using this animal model, we found that B. abortus infected cells and tissues
contained aldose reductase, an enzyme that can account for the production of erythritol
from pentose cycle precursors.
Keywords: Brucella, erythritol, aldose reductase, murine model, bovine trophoblast, human trophoblast, pentose
phosphate cycle, polyol pathway
INTRODUCTION
To survive and multiply any pathogen must harvest nutrients and consequently adapt to the
carbon, energy and nitrogen sources that are available in the host. Pathogenesis is therefore not only
a matter of virulence determinants, metabolism also enables virulence (de Lorenzo, 2014; Nataro,
2015). In this context, a paradigm of the correlation between metabolism and pathogenicity has
been the preferential use of erythritol by the brucellae (McCullough and Beal, 1951; Smith et al.,
1962), a group of facultative intracellular bacteria that cause brucellosis, a worldwide extended
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zoonosis (Zinsstag et al., 2011). A relevant part of the
symptomatology of this disease is related to the particular tropism
of the pathogen for the reproductive tract of ungulates and swine,
which results in orchitis, epididymitis, abortion and infertility
(Moreno and Moriyón, 2006). Massive intratrophoblastic
colonization occurs in brucellosis by B. abortus in cows,
B. melitensis in goats and sheep, B. ovis in sheep, B. suis in sows
and B. canis in bitches (reviewed in Anderson et al., 1986b), and
the infection of trophoblasts is a key step in the loss of integrity
of the placenta that leads to abortion (Samartino and Enright,
1993) and subsequent dissemination. These events are critical
in the biology of Brucella as these bacteria do not survive long
in the environment and are transmitted mostly by contact with
aborted tissues and fluids as well as venereally and congenitally
(Moreno and Moriyón, 2006). Although not detected in early
studies, more recent literature from endemic areas report a
correlation between adverse pregnancy outcomes and Brucella
infection (Khan et al., 2001; Karcaaltincaba et al., 2010; Al-Tawfiq
and Memish, 2013; Vilchez et al., 2015), and epididymo-orchitis
occurs in up to 20% of infected males (Navarro-Martinez et al.,
2001).
The reasons for the preferential colonization of reproductive
organs by the brucellae are not fully understood, and they may
involve nutritional, immune, and hormonal factors (Samartino
and Enright, 1993; Letesson et al., 2017). One of the molecular
bases that is proposed to account, at least partially, for this
tropism is the existence of erythritol in the target organs of
ungulates (Smith et al., 1962). Present in substantial amounts
in fetal fluids, placenta, seminal vesicles and semen of several
ungulate species (Smith et al., 1962; Keppie et al., 1965; Clark
et al., 1967), this four carbon polyol promotes Brucella growth
at low concentrations and is also a preferred carbon source
(McCullough and Beal, 1951; Smith et al., 1962). Bovine fetal
tissues that were obtained from 6 to 7 months pregnant cattle
(the time after which Brucella abortion often occurs) (Williams
et al., 1962) and chorioallantoic membrane explants (Enright and
Samartino, 1994) have been described to produce high amounts
of erythritol. Nevertheless, other observations are not consistent
with erythritol being the only factor in Brucella localization
in vivo. First, although B. ovis and B. canis are unable to catabolize
erythritol, they cause genital infections and abortion in sheep
and dogs, respectively (Blasco, 1990; Carmichael, 1990). Second,
vaccine B. abortus S19 is inhibited by erythritol (Jones et al.,
1965) (see also below) and can cause genital infections and
abortion in cattle. Third, high erythritol concentrations are not
found in human or rodents (Keppie et al., 1965), hosts in whose
reproductive tracts Brucella can localize and even multiply in
cognate trophoblastic cell lines (Bosseray, 1980, 1983; Tobias
et al., 1993; Kim et al., 2005; Salcedo et al., 2013). This last
evidence, however, may need to be reinterpreted because B. suis
mutants eryB and eryC (see below), which cannot catabolize
erythritol, are attenuated in human macrophage-like THP-1
cells, murine J774 cells and BALB/C mice (Köhler et al., 2002;
Burkhardt et al., 2005). As discussed below, the phenotype
of these mutants suggests the presence of erythritol in these
cells in amounts that are high enough to effect on Brucella
multiplication.
The attenuation observed for some ery mutants has been
attributed to the strong growth inhibition caused by erythritol
that can be observed in vitro (Burkhardt et al., 2005). This
bacteriostatic effect was identified very early as one of the
markers of vaccine B. abortus S19 (Jones et al., 1965) and it
was traced to an interrupted assimilation pathway (see below)
(Sperry and Robertson, 1975). The mechanism of erythritol
catabolism has been recently revised (Barbier et al., 2014)
and proceeds through a five step pathway (Figure 1A). The
first step, catalyzed by the EryA kinase, is an ATP-dependent
phosphorylation that, while highly efficient, becomes futile
when the downstream pathway is interrupted (i.e., when either
EryB, EryC, EryH or EryI are not functional), as occurs in
B. abortus S19. The consequence is that the ATP that was
invested cannot be recovered and becomes depleted, hence the
observed growth inhibition (Sperry and Robertson, 1975). This
“toxicity” phenotype has prevented the carrying out of mutant-
based analyses to investigate whether erythritol is actually used
during infection and to what extent it contributes to Brucella
multiplication during infection.
To clarify these issues, we exploited the phenotypes caused
by mutations in different steps of the erythritol pathway as a
reporting system. This system was based on a comparison of
B. abortus 2308 wild type (WT) and mutants eryA (erythritol
kinase) and eryH (isomerase; blocked in D-3-tetrulose-4-P/D-
erythrulose-4-P conversion) (Figure 1A). As discussed above,
the erythritol kinase mutant is erythritol-tolerant but, since it
cannot metabolize erythritol, it should be attenuated if erythritol
is a crucially needed nutrient (i.e., a major or even the only C
source) in the replicative niche. However, the eryH mutant is
predicted to be erythritol-sensitive, and therefore, it should be
attenuated if erythritol is present. Using this reporting system, we
found that erythritol was available but not required for B. abortus
multiplication in bovine trophoblastic cells and, notably, also in
human trophoblastic cells, in murine and human macrophage-
like cells and in the spleen and conceptus of mice. These results
led us to hypothesize that there should be a source of erythritol
in tissues of mammals other than ungulates, and we present
evidence for the involvement of the host aldose reductase (AR),
an enzyme in the polyol pathway that can catalyze the synthesis
of a plethora of polyols including erythritol.
RESULTS
B. abortus 2308 1eryA and 1eryH
Mutants Are Erythritol-Tolerant and
Sensitive, Respectively
We first constructed the non-polar mutants 1eryA and 1eryH
of B. abortus 2308. Using a chemically defined medium, we
confirmed for 1eryH (Barbier et al., 2014) and demonstrated for
1eryA their inability to grow with erythritol as the sole carbon
source (Supplementary Figure S1). We found no growth defect
in a rich medium that lacked erythritol (2YT [10% yeast extract,
1% tryptone, 5% NaCl]) (Dozot et al., 2010), a result that makes
broader metabolic defects in these mutants unlikely. We made
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FIGURE 1 | Brucella abortus 1eryA and 1eryH are erythritol-tolerant and erythritol-sensitive. (A) Revised erythritol catabolic pathway (the mutants used in this
investigation are circled); (B) Growth of B. abortus 2308 WT, 1eryA, 1eryH and complemented 1eryH mutants in 2YT medium supplemented with increasing
concentrations of erythritol. Values are the average of biological and technical triplicates plus the standard deviation (∗p < 0.05; ∗∗∗p < 0.001 [Student’s t-test]).
the same observation using a 1eryI mutant (not shown), which
was as expected.
A critical requirement for using these mutants as reporters
of erythritol availability was that 1eryA and 1eryH should
be erythritol-tolerant and erythritol-sensitive, respectively. To
prove these correlation, we grew 1eryA and 1eryH in 2YT
medium that was supplemented with increasing concentrations
of erythritol (Figure 1B). Whereas erythritol did not affect the
growth of the mutant 1eryA at the highest concentration tested,
it markedly inhibited the growth of the mutant 1eryH at a
concentration as low as 0.05 g/L, which is in the inhibitory range
for vaccine S19 (Keppie et al., 1967) and for an eryC mutant
of B. suis 1330 (Burkhardt et al., 2005). Since we could restore
the WT phenotype of the 1eryH mutant by complementation
(Figure 1B), we concluded that deletion of eryH caused both the
inability to grow on erythritol and its toxicity. As expected from
the activity of EryI (downstream of EryA, Figure 1A), the 1eryI
mutant was also inhibited by erythritol (not shown) and, as it
phenocopied 1eryH, below we present only the data obtained
with the latter mutant.
Another critical requirement of any reporter system is
specificity. To test the specificity, we studied the growth of WT
and 1eryH in 2YT medium supplemented with polyols (0.1 g/L)
with structures close to erythritol (Supplementary Figure S2)
that have been reported in male or pregnant female genital organs
(Clark et al., 1967; Brusati et al., 2005; Jauniaux, 2005; Regnault
et al., 2010; Larose et al., 2012). Since we did not detect any
inhibitory effects for glycerol, ribitol, arabitol, xylitol, sorbitol,
mannitol or dulcitol, the toxicity was specific for erythritol.
Erythritol Is Available But Not Essential
for B. abortus Multiplication in Bovine
and Human Trophoblastic Cells
Since brucellae multiply intensively in bovine trophoblasts
(Anderson and Cheville, 1986; Anderson et al., 1986a), we tested
our reporting system in a suitable bovine trophoblastic cell line
(Samartino et al., 1994). As shown in Figure 2A, no differences
could be evidenced between the WT and the mutants at 2 h
post infection (p.i.), a time when bacteria have not yet reached
their replicative niche (Samartino et al., 1994). At later times,
1eryH (erythritol-sensitive) but not 1eryA (erythritol-tolerant)
failed to multiply at the level of the WT strain. These results
are consistent with the availability of erythritol in the replicative
niche of B. abortus in bovine trophoblasts.
These observations and the recent description that Brucella
can colonize human trophoblastic cell lines (Salcedo et al., 2013;
Fernandez et al., 2016) prompted us to test our reporting system
in trophoblastic cells other than those of bovine origin. When
we infected human BeWo trophoblastic cells with B. abortus
2308 WT, 1eryA or 1eryH, we observed that the mutants
were indistinguishable from the WT 2 h after infection and
that only the multiplication of the erythritol-sensitive mutant
1eryH was significantly reduced at later times (Figure 2B).
These observations are in apparent conflict with previous studies
that reported only very low erythritol concentrations in human
fetal tissues (Keppie et al., 1965; Clark et al., 1967; Amin and
Wilsmore, 1997). However, results obtained with cell lines do not
necessarily reflect the in vivo situation and the parallelism with
the results in bovine trophoblastic cells indicated that, while not
being required for optimal bacterial replication, erythritol should
be available in human BeWo cells at a concentration above that
which is toxic for the sensitive mutant.
Erythritol Is Available But Not Essential
for B. abortus Multiplication in RAW
264.7 and THP-1 Macrophage-Like Cells
Macrophages are another cell type in which Brucella multiplies
extensively. For this reason, RAW 264.7 murine macrophages
and THP-1 human macrophage-like cells were infected with
the erythritol catabolic mutants (Figure 3). Although both were
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FIGURE 2 | Brucella abortus 1eryH but not B. abortus 2308 1eryA or the complemented B. abortus 1eryH (eryH comp.) are attenuated in bovine (A) and human
trophoblastic (B) cells. Values are the average of biological and technical triplicates plus the standard deviation (∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001 [Student’s
t-test]).
able to invade these cells to the same extent as the WT (i.e.,
resulted in the same CFU/ml at 2 h p.i.), the erythritol-sensitive
mutant was found in lower numbers 24 and 48 h after infection.
These results are in agreement with those of Burkhardt et al.
(2005) who showed that a B. suis 1330 1eryC mutant was
erythritol-sensitive and attenuated in macrophages. Indeed, these
authors also reported 1eryC attenuation in mice and suggested
an availability of erythritol in vivo.
Erythritol Availability and Essentiality Are
Time-Dependent in C57BL/6 Mouse
Spleens
In C57BL/6 mice that were infected intraperitoneally with either
B. abortus 2308 WT or the erythritol catabolic mutants, the CFU
numbers/spleen of both 1eryA and 1eryH were significantly
lower than those of the WT 3 days after infection (Figure 4). After
9 days, only the erythritol-sensitive mutant showed significantly
reduced CFU numbers, and consistent with this, splenomegaly
was lower in the corresponding group of mice. Although
splenomegaly was reduced in the 1eryH-infected group, no
differences in the CFU numbers of the mutants were observed
30 days after infection. These results are also in line with those
of Burkhardt et al. (2005) who also found reduced CFU/spleen
for the B. suis 1eryC at early times (7 days or less) but not
28 days after infection. On the other hand, they are only in
partial agreement with those of Sangari et al. (1998). These
authors found that the CFU/spleen of a B. abortus 2308 erythritol
sensitive Tn5 mutant and the parental strain were similar 7, 14,
and 28 days after infection. The discrepancy is thus limited to the
results obtained 7 days after infection but as earlier times were not
studied and the CFU/spleen at longer times coincide with the our
observations, it seems possible that the differences could relate
to the protocols (breed of mice [BalB/c versus C57BL/6], Tn5
polarity effects on regulators downstream and possibly others).
Bearing in mind the properties of the mutants in our reporting
system, these results suggest that the availability and importance
of erythritol as a carbon source in the spleen of mice changes
during the course of infection. During a splenic infection
everything including the bacterial load, the type of infected cells,
the type of recruited cells, the splenic microarchitecture and the
immune environment is evolving in a dynamic way. Therefore,
it may be not so surprising that 3 days after infection (that is to
say before the peak of splenic infection and before any detectable
splenomegaly) Brucella is in a compartment where erythritol is
available (attenuation of 1eryH) but also required (attenuation
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FIGURE 3 | Brucella abortus 1eryH but not B. abortus 2308 1eryA or the complemented B. abortus 1eryH (eryH comp.) are attenuated in human (A) and murine
(B) macrophage-like cells. Values are the average plus the standard deviation of three experiments for THP-1 and of one representative replicate for RAW 264.7
(∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001 [Student’s t-test]).
of 1eryA); later on, changes in one or several parameters (i.e.,
infected cells or immune environment) might lead to a change
in the nutrients that are available which makes erythritol, while
available (attenuation of 1eryH) less needed (no attenuation
of 1eryA). Afterward, erythritol availability would progressively
dwindle because both mutants reached a WT-like bacterial load
at 30 days p.i.
Erythritol Is also Available in the
B. abortus-Infected Murine Conceptus
The well-known genital tropism of Brucella prompted us to
investigate erythritol availability in the mouse conceptus. We
infected C57BL/6 mice in either early (6 days) or late (14 days)
pregnancy with B. abortus WT, 1eryA and 1eryH (Bosseray,
1980). Then, we determined the CFU in fetuses, placenta and fetal
envelopes 1 and 9 days p.i., which in both groups corresponds
to post-conception day 15. The results (Figure 5) showed a
systemic distribution of the three strains in the conceptus with
the placenta being be the most heavily infected organ, as expected
from its barrier function (Bosseray, 1980). For the mice that were
infected at day 6 post-conception, only the erythritol-sensitive
strain 1eryH was present in significantly lower numbers in the
fetus and placenta. When mice were infected late in pregnancy,
only 1eryH was attenuated, and attenuation was observed in all
tissues. These results strongly suggest that erythritol is available
but not crucially required for B. abortus to multiply in the murine
conceptus.
Aldose Reductase Is Expressed in RAW
264.7 Macrophages and Tissues Infected
by B. abortus
The polyol pathway has been suggested to be involved in the
synthesis of erythritol in mammalian tissues (Pearce et al., 1962)
and the key enzyme, AR, can catalyze the conversion of erythrose
into erythritol (Hayman and Kinoshita, 1965; Kardon et al.,
2008). Thus, we examined whether there was a connection
between AR and the ability of Brucella to multiply in cells and
tissues.
First, we studied whether AR is expressed in some of the
cells in which our reporting system indicated the presence
of erythritol. We found that the enzyme was detectable by
immunofluorescence and that AR gene expression was observed
in uninfected RAW 264.7 macrophages that were cultured
in standard media; no noticeable changes were noted when
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FIGURE 4 | The B. abortus erythritol catabolic mutants 1eryA and 1eryH are attenuated in C57BL/6 mice. Mice were infected with 5 × 104 CFU, and CFU in the
spleen (A) and spleen weights (B) determined at the indicated intervals. Each dot represents the CFU counts of one individual mouse, and bars the
mean ± standard deviation (∗p < 0.01; ∗∗p < 0.001; Mann–Whitney test).
these cells were infected by Brucella (data not shown). Since
AR is induced by hyperglycemia (≥20 mM glucose; 5 mM
being normoglycemic) (González et al., 1984; Tawata et al.,
1992) and the DMEM-HG culture medium contains 25 mM
glucose, we also measured the dependence of the expression
of gene Akr1b3 (which codes for mouse AR) on glucose
as an indirect and complementary test for AR activity. In
RAW 264.7 macrophages that were grown in a range (2.8
[0.5 g/L], 5.6 [1.0 g/L] and 25 mM [4.5 g/L]) of glucose
concentrations, we found that expression of Akr1b3 was
modulated by glucose (Figure 6A), a result that strongly suggests
that AR is active in these cells in culture. Although the glucose
concentration did not affect the multiplication of the 1eryH
mutant during the first 2 h after infection, its inhibition
was significant at 24 and 48 h (Figure 6B) suggesting that
erythritol is available in cells that are grown in the range
of physiological glucose concentrations that induce AR gene
expression.
Second, we examined the AR and bacterial distributions in
the conceptuses of mice that were infected intraperitoneally with
B. abortus 2308-mCherry at 6 days post conception. Bacteria
and AR-positive cells were located preferentially in the junctional
zone of the placenta just underneath the decidua basalis and in
a cellular sheet surrounding the fetus apposed on the internal
face of the distended decidua parietalis (Figure 7A). Infected
cells were positive for cytokeratin 7 (Figures 7B,C) and thus
trophoblastic in nature (Croy et al., 2013), probably being
trophoblastic giant cells (Kim et al., 2005). As expected, some
infected trophoblasts were also scattered in the decidua after
mid-gestation (Hu and Cross, 2010). Bacteria were found almost
exclusively in AR-positive cells (Figure 8).
Finally, we investigated mouse spleens 9 days after infection,
a time at which the erythritol-sensitive strain 1eryH showed
attenuation. We found intense AR-staining in the red pulp
(Supplementary Figure S3), with small clusters of CD11b-
positive cells [often iNOS positive and corresponding to
granulomas (Copin et al., 2012)], which are frequently associated
with AR. In contrast, we hardly detected AR in spleens of
non-infected mice; when we did, AR was mostly restricted to
scattered CD11b-negative cells in the red pulp.
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FIGURE 5 | Brucella abortus1eryH but not 1eryA show reduced ability to
colonize the mouse conceptus. Pregnant C56BL/6 mice were inoculated
intraperitoneally with 105 B. abortus 2308 WT, 1eryH or 1eryA mutant at 6 or
14 days post conception (P-C). At day 15 P-C, individual conceptuses were
dissected to separate the placenta (P), the fetus (F) and the fetal envelopes (E)
and CFU determined. Each dot represents the CFU counts obtained from one
conceptus and bars represent the mean ± standard deviation (∗∗p < 0.01;
∗∗∗p < 0.001; Mann–Whitney test).
DISCUSSION
In this work, we set up and validated a reporting system
to detect the presence and catabolism of erythritol in the
Brucella replicative niche, and this system demonstrated
the availability of this polyol in infection models of bovine,
human and murine origin, extending previous research
in macrophages and mice (Burkhardt et al., 2005) to
trophoblastic cell lines. Indeed, because erythritol is present
in comparatively large amounts in the placenta and genital
tissues of ruminants and swine and because Brucella is
found inside trophoblastic cells of ruminants and uses
erythritol very efficiently, it has been widely assumed that
trophoblasts produce erythritol. However, most evidence
is limited to extracts of fetal allantoic and amniotic fluids,
cotyledons, whole placenta, seminal vesicles and testis
(Smith et al., 1962; Williams et al., 1962; Clark et al.,
1967), and to the best of our knowledge, only one work
has reported the presence of erythritol in trophoblasts of
bovine origin (Enright and Samartino, 1994). Our work
confirms this pattern and provides the first experimental
data that support the presence of erythritol in human and
murine trophoblastic cells. In addition, we demonstrate
for the first time that the catabolism of erythritol is not
essential to the infectious processes in these infection
models.
The fact that bovine and human trophoblastic cells and
murine models give similar results contrasts with the low
erythritol concentrations that were reported in fetal fluids
of humans and mice (approximately 60 µg/ml in cows and
less than 2 µg/ml in humans or mice) (Keppie et al.,
1965; Amin and Wilsmore, 1997). Based on our in vitro
toxicity assays in 2YT, it can be speculated that erythritol
concentration should reach 50–100 µg/ml to result in 1eryH
attenuation during infection. If correct, these differences in
erythritol measurements in fetal fluids could reflect the particular
composition of the Brucella replicative niche during infection.
It is apparently puzzling that, although our reporting system
shows that erythritol is catabolized “in vivo,” it also shows
that erythritol is not an essential carbon source, indicating a
complex nutritional situation in the replicative niche where
erythritol, but also alternative C sources, should be available
in various and evolving proportions based on the time of
infection, the type of cell infected and other variables. A possible
explanation for this situation could be the presence of an
active polyol pathway because this pathway (which depends on
AR; see below) can supply not only erythritol but also other
polyols such as glycerol, arabitol, mannitol and inositol that
are in fact found in fetal tissues and reproductive systems of
several Brucella hosts (Jauniaux, 2005). These polyols, erythritol
included, may not be critical individually but could be alternative
carbon sources. Of course, a definite answer needs specific
investigations carried out in the natural host species, not
only with B. abortus, B. melitensis and B. suis but also with
B. ovis and B. canis, the two classical species not stimulated by
erythritol.
Since our reporting system showed erythritol in cells in
which its presence has not been described, we looked for
possible biosynthetic mechanisms in mammal tissues. Over
50 years ago, Pearce et al. (1962) proposed that erythritol “may
arise from D-erythrose [ . . .] as an intermediate between D-
erythrose and D-erythrulose as sorbitol acts as an intermediate
between glucose and fructose.” The enzyme responsible for the
conversion of glucose to sorbitol is the aldose reductase (AR,
AKR1B1 in human and bovines, AKR1B3 in mice) of the
polyol pathway, which oxidizes sorbitol to fructose. Thus, we
investigated the presence of AR in cells and tissues where
B. abortus multiplied and where the presence of erythritol
Frontiers in Microbiology | www.frontiersin.org 7 June 2017 | Volume 8 | Article 1088
fmicb-08-01088 June 10, 2017 Time: 15:44 # 8
Barbier et al. Erythritol and Brucella
FIGURE 6 | The expression of Aldose reductase gene Akr1b3 in RAW 264.7 macrophages depends on glucose concentration. (A) Expression of gene Akr1b3
measured by qRTPCR in macrophages cultured with 0.5, 1, and 4.5 g/L of glucose. (B) Multiplication of B. abortus 2308 WT and 1eryH in macrophages cultured
with 0.5, 1, and 4.5 g/L of glucose. All experiments were performed in biological and technical duplicates (∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001 [Student’s t-test]).
was detected. We found that AR was present in RAW 264.7
macrophages independently of an infection, that 9 days after
infection there was a sharp increase in AR in the splenic
red pulp where clusters of CD11b+ (indicative of Brucella-
induced granulomas) cells co-localized with AR and that AR
and B. abortus co-localized in the infected murine conceptus.
There is abundant indirect evidence that this coexistence
of AR and brucellae in the laboratory models parallels the
situation in the natural hosts. Actually, tissues characteristically
targeted by brucellae such as the placenta of cows, sheep
and pigs, and the epididymis, seminal fluids and oviduct of
pigs, cattle and some rodents, which are among those tissues
whose fructose concentrations are high or are predominant
over glucose, contain abundant amount of AR (Clark et al.,
1967; Frenette, 2006; Pruneda et al., 2006). Moreover, AR
(AKR1B1) has also been recently identified by proteomics as
differentially produced in bovine chorioallantoic membranes
that were infected by Brucella (Mol et al., 2016). Indeed, AR
can reduce a broad range of aldehydes to their corresponding
alcohols (Håstein and Velle, 1968) and significantly its affinity
is far higher for erythrose than for glucose (Hayman and
Kinoshita, 1965; Kardon et al., 2008). Furthermore, a role of
AR in erythritol generation in these tissues is consistent with
the fact that the pentose phosphate pathway, which can supply
D-erythrose, is active in testes, ovaries and placenta (Ferrier,
2013). Although further research is necessary, all these indirect
evidences together with the data presented here, lend support
to the hypothesis that AR accounts for erythritol production
in cells that have been invaded by brucellae, as well as for the
apparently puzzling observation that erythritol is not essential
for Brucella multiplication. In preliminary experiments, we have
found that treatment of murine macrophages with the potent
AR inhibitor Sulindac (Ratliff et al., 1999) impairs B. abortus
2308 intracellular multiplication, an observation that is also
consistent with our hypothesis. It is also worth commenting
that AR is a moonlighting protein that in addition to its
function in the polyol pathway, has been linked to inflammation
regulation (Ramana and Srivastava, 2010) and is involved in the
hormonal regulation of pregnancy and parturition. Some AR
are, as a matter of fact, involved in progesterone degradation
and are also the main human, murine and bovine prostaglandin
F2α (PGF2α) synthase (Madore et al., 2003; Kabututu et al.,
2008; Bresson et al., 2011, 2012). It is thus tempting to
hypothesize that AR could represent an actor in the context
of Brucella–host interaction at the crossroad of metabolism,
inflammation and abortion, a possibility that deserves further
investigation.
MATERIALS AND METHODS
Bacterial Strains and Culture Conditions
Escherichia coli DH10B were grown in LB medium. B. abortus
2308 NalR and derived strains were grown at 37◦C in rich
medium 2YT (16 g/L bacto tryptone 10 g/L yeast extract
and 5 g/L NaCl; BD Difco) or in a chemically defined
medium (Barbier et al., 2014) composed of 2.3 g/L K2HPO4;
3 g/L KH2PO4; 0.1 g/L Na2S2O3; 5 g/L NaCl; 0.2 g/L
nicotinic acid; 0.2 g/L thiamine; 0.07 g/L pantothenic acid;
0.5 g/L (NH4)2SO4; 0.01 g/L MgSO4; 0.1 mg/L MnSO4;
0.1 mg/L FeSO4; 0.1 mg/L biotin and 2 g/L of erythritol.
Growth was monitored using an automated plate reader
(Bioscreen C, Lab Systems) following the OD (600 nm)
with continuous shaking at 37◦C. The growth rate was
calculated as follows:
(
ln (ODt2)− ln (ODt1)) / (t2− t1).
The 1t was set for 7 h, i.e., approximately two division
times, and incremented over the log phase every 0.5 h
(0–7 h; 0.5–7.5 h,. . .) resulting in a set of values whose mean
is the average growth rate, µ. When required, the medium
was supplemented with chloramphenicol (20 mg/ml), nalidixic
acid (25 mg/ml), sucrose (5%), agar (15 g/L, BD Difco)
and polyols (concentrations annotated in the manuscript).
Unless otherwise stated, reagents were purchased from
Sigma–Aldrich.
Construction of an mCherry-producing B. abortus
2308 strain was performed following the same procedure
that was validated for B. melitensis (Copin et al., 2012).
Construction of the in-frame deletion in eryA was done
following a previously described strategy (Barbier et al.,
2014). Briefly, approximately 750 bp upstream and
downstream of BAB2_0372 were amplified by PCR from
genomic DNA of B. abortus 2308. The obtained PCR
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FIGURE 7 | Localization of B. abortus 2308 in murine conceptus. Pregnant mice were infected intraperitoneally at 6 days post-conception with 105 CFU of
B. abortus mCherry (white), and the conceptuses were obtained at post-conception day 15. (A) Mosaic reconstitution (210 individual images taken at 10×
magnification) of a sagittal section of an infected murine conceptus stained for DNA (DAPI/blue) and actin (phalloidin/green); dashed squares B and C circumscribe
the prototypal zone corresponding to (B,C). (B) Cytokeratine-7 immunostaining (light blue) of trophoblastic cells of the dorsal part of the conceptus with a close up
of the infected trophoblastic cells lining the decidua parietalis (yellow square). (C) Cytokeratine-7 immunostaining (light blue) of the placenta at the level of the
decidua basalis. TGC, trophoblast giant cell; ST, spongiotrophoblast; L, labyrinth.
products were, respectively, flanked by SpeI/BamHI (SpeI_F:
5′-ACTAGTCTTGGCGGAAACTTGACTGG-3′; BamHI_R: 5′-
ATACGCGGATCCGCGATAACGCATGGCTGACACAGG-3′)
and BamHI/SphI restriction sites (BamHI_F: 5′-
TATCGCGGATCCGCGTATGGCAAATAAGGAAACATTGA
ATG-3′; SphI_R: 5′-GCATGCGCGCTTGTCGTGGTTCTG-3′).
A third PCR joined the two fragments together using primers
SpeI_F and SphI_R, which was followed by ligating this
product into an EcoRV-digested pGEM plasmid (Promega).
After sequence verification (Beckman Coulter Genomics),
the ±1500 bp insert was excised as a SpeI – SphI fragment
and cloned into a pNPTS138 suicide vector (KanR, SucS).
The acquisition of this vector by Brucella after mating with
conjugative S17 E. coli was selected by kanamycin and nalidixic
acid resistance. The loss of the plasmid concomitant with either
a deletion or a return to WT phenotype was then selected
on sucrose. Mutants were identified using PCR with primers
that were located external to the deletion. The 1eryH and
1eryI strains were previously characterized (Barbier et al.,
2014). For complementation, eryH was amplified by PCR
from genomic DNA of B. abortus 2308 as a BamHI/XhoI
fragment (BamHI_F: 5′-gcgggatccatgaccaaattctggattgg-3′;
XhoI_R: 5′-ttaattcgcttgaaccttggctcgagccg-3′). Fragments were
cloned into an EcoRV-digested pGEM, sequenced and then
transferred into a pBBR1MCS1 (CmR). The 1eryH strain with
the construct was then transformed by conjugation with the
construction and selected for with the newly acquired resistance
to chloramphenicol.
All Brucellawere handled under BSL-3 containment according
to the Directive 98/81/CE du Conseil du 26 octobre 1998
and to a law of the Gouvernement wallon du 4 juillet
2002.
Cell Culture and Infection
RAW 264.7 murine macrophages were routinely cultured
in Dulbecco’s modified Eagle’s medium with high glucose
(DMEM, Gibco) supplemented with 10% heat-inactivated fetal
calf serum (FCS, Gibco). THP-1 human macrophage-like
cells were cultured in RPMI 1640 medium (Gibco) that was
supplemented with 10% FCS and 2 mM L-glutamine. Cells
were differentiated into adherent monocytes by overnight
treatment with 5 nM phorbol myristate (PMA). Bovine
trophoblastic CL2 cells were kindly provided by Pr. Cynthia
Baldwin (University of Massachusetts, Amherst, MA, United
States) and cultured in RPMI 1640 supplemented with 10%
FCS and 0.05 mM 2-mercaptoethanol (Gibco) as previously
described (Parent et al., 2012). BeWo human trophoblastic
cells (ATCC clone CCL-98) were cultured in DMEM-F12
Ham medium (Gibco) that was supplemented with 10% FCS
and 2 mM L-glutamine as already described (Salcedo et al.,
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FIGURE 8 | Aldose reductase localization in B. abortus infected murine conceptus. Pregnant mice were intraperitoneally infected at post-conception day 6 with 105
CFU of a B. abortus mCherry (mCherry-Br; white color). Conceptus were obtained at post-conception day 15 and stained for DNA (DAPI/blue) and actin
(phalloidin/green). (A) Aldose reductase immunostaining (purple) of the trophoblastic layer surrounding the fetus (the area in the yellow square corresponds to the
lower left panel of the Figure). (B) Aldose reductase immunostaining (purple) of the placenta at the level of the decidua basalis.
2013). All cells were maintained at 37◦C with a 5% CO2
atmosphere.
For experiments in which RAW 264.7 were cultured with
various glucose concentrations, DMEM with no glucose (Gibco)
was supplemented with the appropriate amount of filter-sterilized
glucose. Cells were cultured under these conditions for at least
2 passages prior to infection. Infections were performed as
described elsewhere (Salcedo et al., 2013; Zúñiga-Ripa et al.,
2014). Briefly, cells were seeded in 24-well plates at an appropriate
density (2.105 cells/ml THP-1 cells and 4.104 cells/ml for RAW
264.7 and trophoblastic cells) and infected 24 h later with a
multiplicity of infection (MOI) of 100. The cells were centrifuged
at 1000 RPM for 10 min at 4◦C before being incubated for 1 h at
37◦C with 5% CO2; they were then washed with fresh medium
and incubated for 1 h with medium containing 50 µg/ml of
gentamicin. The medium was then replaced with a fresh medium
that contains 10 µg/ml of this antibiotic. At 2, 24, and 48 h after
infection, cells were washed with PBS and treated for 10 min
at room temperature with PBS Triton X100 0.1%; after this
treatment, the lysates were collected, diluted, plated on TSB and
incubated at 37◦C for approximately 3 days to enumerate the
CFUs.
For immunofluorescence staining, cells were seeded on
coverslip and treated as described previously (Francis et al.,
2017). At the end of the process, the cells were fixed in 2%
paraformaldehyde, pH 7.4, at 37◦C for 15 min.
C57BL/6 Mice Infection
The procedures used and the handling of mice complied with
current European legislation (directive 86/609/EEC) and the
corresponding Belgian law “Arrêté royal relatif à la protection
des animaux d’expérience du 6 avril 2010 publié le 14 mai
2010.” The Animal Welfare Committee of the Université de
Namur (Belgium) reviewed and approved the complete protocols
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(Permit Number 16/277). All infections were performed at an
Animal Biosafety Level 3 facility.
To obtain the inoculum, bacteria from an overnight culture
of Brucella in rich medium were pelleted, washed with RPMI
1640 and diluted in this medium. Intraperitoneal infection was
carried out as previously described (Copin et al., 2012). Briefly,
500 µl of suspension (105 CFU) was injected into groups of 8 to
12 C57BL/6 mice for each tested strain. Mice were euthanized 3,
9, and 30 days post-infection by cervical dislocation, the spleens
were isolated, weighted and homogenized in 1 ml of PBS Triton
X100 0.1%, and the CFU were counted on tryptic soy agar
plates.
The procedure that was used to infect pregnant mice was
adapted from previous reports (Bosseray, 1982; Kim et al., 2005;
Pennington et al., 2012). Estruses of 6–14 weeks old C57BL/6
females were synchronized 3 days before mating pairs were set
up with males that were 3–4 months old. Then, the presence
of a vaginal plug was checked daily, and potentially fertilized
females were isolated. That day corresponds to day 0 post-
fecundation (PF). Four to five pregnant females were infected
intraperitoneally with 500 µl of bacterial suspension that was
prepared as previously described (105 bacteria) at day 6 or
14 PF. At day 15 PF, mice were anesthetized with isoflurane
(Zoetis) and euthanized by cervical dislocation. Conceptuses
were removed from maternal uterine horns and transferred
to sterile Petri dishes on ice, where they stayed for 15 min.
Placenta, fetuses and surrounding fetal membranes were then
further isolated and weighed. Tissues were homogenized in 1 ml
PBS Triton X100 0.1% with an Ultra-Turrax homogenizer, the
homogenates were serially diluted in PBS, and their CFU were
counted.
Immunofluorescence Microscopy
Fetuses and spleens were fixed for 2 h at room temperature in
2% paraformaldehyde (pH 7.4), washed in PBS, and incubated
overnight at 4◦C in a 20% PBS-sucrose solution. The tissues
were then embedded in Tissue-Tek OCT compound (Sakura)
and frozen in liquid nitrogen, and cryostat sections (thickness,
5 µm for spleens and 10 µm for fetus) were prepared. For the
staining, tissue sections were rehydrated in PBS and incubated
in a PBS solution that contained 1% blocking reagent (PBS-BR
1%, Boehringer) for 20 min before they were incubated overnight
in PBS-BR 1% containing mAbs or the following reagents:
DAPI nucleic acid stain Alexa Fluor 350 or 488 phalloidin
(Molecular Probes) to visualize the structure of the organ, and rat
biotin-coupled anti-mouse CD11b (BD Pharmingen), rabbit anti-
mouse iNOS (Calbiochem), rabbit anti-mouse Cytokeratin 7 (ab
181598, Abcam), and rabbit anti-mouse AR (CPA3124, Cohesion
Biosciences) to stain the cells of interest. The samples were
incubated with the appropriate secondary reagents [Alexa Fluor
568 streptavidin (Molecular Probes) or Alexa Fluor 647-coupled
donkey anti-rabbit IgG (Molecular Probes)] for 2 h. Slides
were mounted in Fluoro-Gel medium (Electron Microscopy
Sciences, Hatfield, PA, United States). Labeled tissue sections
were visualized with an Axiovert M200 inverted microscope
(Zeiss, Iena, Germany) that was equipped with a high-resolution
monochrome camera (AxioCam HR, Zeiss).
Images (1384 pixels × 1036 pixels, 0.16 µm/pixel) were
acquired sequentially for each fluorochrome with A-Plan
10×/0.25 N.A. and LD-Plan-NeoFluar 63×/0.75 N.A. dry
objectives and recorded as eight-bit gray-level ∗.zvi files. At
least three slides per organ were analyzed from three different
animals, and the results are representative of two independent
experiments.
For immunostaining of AR in RAW 264.7 murine
macrophages, the primary antibody that was used was the
same that was used for staining in mice with a goat anti-rabbit
IgG Alexa 488 (Life Technologies) as the secondary antibody.
Measurement of the Murine Aldose
Reductase AKR1B3 Expression in RAW
264.7 by qRT-PCR
RNA from cells cultivated in a T75 flask was extracted with
TriPure isolation reagent (Roche) according to the instructions
of the manufacturer and DNA contamination was eliminated
by incubation with DNase I (Fermentas). Then, RNA was first
reverse transcribed (two steps) by SuperScript II (Invitrogen)
into cDNA, which was then amplified in a LightCycler 96
Instrument (Roche) with FastStart Universal SYBR Green
Master (Roche) as the fluorescent dye. The specificity of the
SYBR Green assays was assessed by melting-point analysis
and gel electrophoresis. The results were normalized using the
housekeeping b-actin gene. Primer sequences are described in
Supplementary Table S1.
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FIGURE S1 | Brucella abortus 2308 1eryA and 1eryH are not able to grow
with erythritol as the only carbon source. The growth of the 1eryA mutant
was monitored in rich medium 2YT or in chemically defined medium with erythritol
as the only carbon source and compared to 1eryH {Barbier:2014 cm}. As
expected, the growth of the deletion strains is abolished when only erythritol is
available.
FIGURE S2 | The growth of the erythritol-sensitive B. abortus 2308 1eryH strain
is not affected by other polyols. Growth was monitored in 2YT supplemented with
polyols structurally close to erythritol that are also found in fetal fluids and tissues.
The growth of the 1eryH mutant was not affected by any of the polyols tested
strongly suggesting that the toxicity is specific for erythritol. The experiment was
performed in biological triplicates and technical duplicates. Values represent the
average of one representative experiment ± standard deviation (shaded gray and
dashed lines).
FIGURE S3 | Aldose reductase localization in the spleen of mice infected with
B. abortus 2308. Mice were infected intraperitoneally with 105 CFU of B. abortus
2308, spleens obtained at day 9 post infection and stained for actin
(phalloidin/gray) and CD11b (green). (A) iNOS immunostaining (blue) of spleen
sections of non-infected (control, Left), and infected (Br.9d, Right), mice. The red
pulp shows small clusters of CD11b-positive cells (often iNOS positive) that
correspond to Brucella granulomas {Copin:2012ee}. (B) Aldose reductase
immunostaining (purple) of spleen sections of non-infected and infected mice. In
the non-infected mice (control, Left), aldose reductase was scarcely detected and
was restricted to a few and CD11b-negative cells of the red pulp. In infected mice
9 days post-infection (Br.9d, Right), aldose reductase was abundant in the red
pulp in the same areas where the Brucella granulomas developed.
REFERENCES
Al-Tawfiq, J. A., and Memish, M. A. (2013). Pregnancy associated
brucellosis. Recent Pat. Antiinfect. Drug Discov. 8, 47–50. doi: 10.2174/
1574891X11308010009
Amin, J. D., and Wilsmore, A. J. (1997). The effects of crude placental extract
and erythritol on growth of Chlamydia psittaci (ovis) in McCoy cells. Vet. Res.
Commun. 21, 431–435. doi: 10.1023/A:1005807402736
Anderson, T. D., and Cheville, N. F. (1986). Ultrastructural morphometric analysis
of Brucella abortus-infected trophoblasts in experimental placentitis. Bacterial
replication occurs in rough endoplasmic reticulum. Am. J. Pathol. 124,
226–237.
Anderson, T. D., Cheville, N. F., and Meador, V. P. (1986a). Pathogenesis of
placentitis in the goat inoculated with Brucella abortus. II. Ultrastructural
studies. Vet. Pathol. 23, 227–239.
Anderson, T. D., Meador, V. P., and Cheville, N. F. (1986b). Pathogenesis of
placentitis in the goat inoculated with Brucella abortus. I. Gross and histologic
lesions. Vet. Pathol. 23, 219–226.
Barbier, T., Collard, F., Zúñiga-Ripa, A., Moriyón, I., Godard, T., Becker, J.,
et al. (2014). Erythritol feeds the pentose phosphate pathway via three
new isomerases leading to D-erythrose-4-phosphate in Brucella. Proc.
Natl. Acad. Sci. U.S.A. 111, 17815–17820. doi: 10.1073/pnas.14146
22111
Blasco, J. M. (1990). “Brucella ovis,” in Animal Brucellosis, eds K. H. Nielsen and
J. R. Ducan (Boca Raton, FL: CRC Press), 352–378.
Bosseray, N. (1980). Colonization of mouse placentas by Brucella abortus
inoculated during pregnancy. Br. J. Exp. Pathol. 61, 361–368.
Bosseray, N. (1982). Mother to young transmission of Brucella abortus infection in
mouse model. Ann. Rech. Vét. 13, 341–349.
Bosseray, N. (1983). Kinetics of placental colonization of mice inoculated
intravenously with Brucella abortus at day 15 of pregnancy. Br. J. Exp. Pathol.
64, 612–616.
Bresson, E., Boucher-Kovalik, S., Chapdelaine, P., Madore, E., Harvey, N., Laberge,
P. Y., et al. (2011). The human aldose reductase AKR1B1 qualifies as the primary
prostaglandin F synthase in the endometrium. J. Clin. Endocrinol. Metab. 96,
210–219. doi: 10.1210/jc.2010-1589
Bresson, E., Lacroix-Pépin, N., Boucher-Kovalik, S., Chapdelaine, P., and Fortier,
M. A. (2012). The prostaglandin F synthase activity of the human aldose
reductase AKR1B1 brings new lenses to look at pathologic conditions. Front.
Pharmacol. 3:98. doi: 10.3389/fphar.2012.00098/abstract
Brusati, V., Józ´wik, M., Józ´wik, M., Teng, C., Paolini, C., Marconi, A. M.,
et al. (2005). Fetal and maternal Non-glucose carbohydrates and polyols
concentrations in normal human pregnancies at term. Pediatr. Res. 58, 700–704.
doi: 10.1203/01.PDR.0000180549.86614.73
Burkhardt, S., Jiménez de Bagüés, M. P., Liautard, J.-P., and Köhler, S. (2005).
Analysis of the behavior of eryC mutants of Brucella suis attenuated in
macrophages. Infect. Immun. 73, 6782–6790. doi: 10.1128/IAI.73.10.6782-6790.
2005
Carmichael, L. E. (1990). “Brucella canis,” in Animal Brucellosis, eds K. H. Nielsen
and J. R. Ducan (Boca Raton, FL: CRC Press), 336–350.
Clark, J. B., Graham, E. F., Lewis, B. A., and Smith, F. (1967). D-mannitol, erythritol
and glycerol in bovine semen. J. Reprod. Fertil. 13, 189–197. doi: 10.1530/jrf.0.
0130189
Copin, R., Vitry, M.-A., Hanot Mambres, D., Machelart, A., De Trez, C.,
Vanderwinden, J.-M., et al. (2012). In situ microscopy analysis reveals local
innate immune response developed around Brucella infected cells in resistant
and susceptible mice. PLoS Pathog. 8:e1002575. doi: 10.1371/journal.ppat.
1002575.g009
Croy, B. A., Yamada, A. T., DeMayo, F. J., and Adamson, S. L. (2013). The Guide to
Investigation of Mouse Pregnancy. Amsterdam: Academic Press.
de Lorenzo, V. (2014). From the selfish gene to selfish metabolism: revisiting the
central dogma. Bioessays 36, 226–235. doi: 10.1002/bies.201300153
Dozot, M., Poncet, S., Nicolas, C., Copin, R., Bouraoui, H., Mazé, A., et al. (2010).
Functional characterization of the incomplete phosphotransferase system
(PTS) of the intracellular pathogen Brucella melitensis. PLoS ONE 5:e12679.
doi: 10.1371/journal.pone.0012679
Enright, F. M., and Samartino, L. E. (1994). Mechanisms of abortion in Brucella
abortus infected cattle. Proc. Annu. Meet U.S. Anim. Health Assoc. 98, 55–63.
doi: 10.1186/1471-2164-14-426
Fernandez, A. G., Ferrero, M. C., Hielpos, M. S., Fossati, C. A., and Baldi, P. C.
(2016). Proinflammatory response of human trophoblastic cells to Brucella
abortus infection and upon interactions with infected phagocytes. Biol. Reprod.
94, 48. doi: 10.1095/biolreprod.115.131706
Ferrier, D. R. (ed.) (2013). Biochemistry, 6 Edn. Hagerstwon: Lippincott Williams &
Wilkins.
Francis, N., Poncin, K., Fioravanti, A., Vassen, V., Willemart, K., Ong, T. A. P.,
et al. (2017). CtrA controls cell division and outer membrane composition of
the pathogen Brucella abortus. Mol. Microbiol. 103, 780–797. doi: 10.1111/mmi.
13589
Frenette, G. (2006). Polyol pathway in human epididymis and semen. J. Androl. 27,
233–239. doi: 10.2164/jandrol.05108
González, R. G., Barnett, P., Aguayo, J., Cheng, H. M., and Chylack, L. T. (1984).
Direct measurement of polyol pathway activity in the ocular lens. Diabetes
Metab. Res. Rev. 33, 196–199. doi: 10.2337/diab.33.2.196
Håstein, T., and Velle, W. (1968). Placental aldose reductase activity and
foetal blood fructose during bovine pregnancy. J. Reprod. Fertil. 15, 47–52.
doi: 10.1530/jrf.0.0150047
Hayman, S., and Kinoshita, J. H. (1965). Isolation and properties of lens aldose
reductase. J. Biol. Chem. 240, 877–882.
Hu, D., and Cross, J. C. (2010). Development and function of trophoblast giant
cells in the rodent placenta. Int. J. Dev. Biol. 54, 341–354. doi: 10.1387/ijdb.
082768dh
Jauniaux, E. (2005). Polyol concentrations in the fluid compartments of the
human conceptus during the first trimester of pregnancy: maintenance of
redox potential in a low oxygen environment. J. Clin. Endocrinol. Metab. 90,
1171–1175. doi: 10.1210/jc.2004-1513
Frontiers in Microbiology | www.frontiersin.org 12 June 2017 | Volume 8 | Article 1088
fmicb-08-01088 June 10, 2017 Time: 15:44 # 13
Barbier et al. Erythritol and Brucella
Jones, L. M., Montgomery, V., and And Wilson, J. B. (1965). Characteristics of
carbon dioxide-independent cultures of Brucella abortus isolated from cattle
vaccinated with strain 19. J. Inf. Dis. 115, 312–320. doi: 10.1093/infdis/115.3.312
Kabututu, Z., Manin, M., Pointud, J. C., Maruyama, T., Nagata, N., Lambert, S.,
et al. (2008). Prostaglandin F2 synthase activities of aldo-keto reductase 1B1,
1B3 and 1B7. J. Biochem. 145, 161–168. doi: 10.1093/jb/mvn152
Karcaaltincaba, D., Sencan, I., Kandemir, O., Guvendag Guven, E. S., and
Yalvac, S. (2010). Does brucellosis in human pregnancy increase abortion risk?
Presentation of two cases and review of literature. J. Obstet. Gynaecol. Res. 36,
418–423. doi: 10.1111/j.1447-0756.2009.01156.x
Kardon, T., Stroobant, V., Veiga-da-Cunha, M., and Van Schaftingen, E.
(2008). Characterization of mammalian sedoheptulokinase and mechanism
of formation of erythritol in sedoheptulokinase deficiency. FEBS Lett. 582,
3330–3334. doi: 10.1016/j.febslet.2008.08.024
Keppie, J., Williams, A., Witt, K., and Smith, H. (1965). The role of
erythritol in the tissue localization of the brucellae. Br. J. Exp. Pathol. 46,
104–108.
Keppie, J., Witt, K., and Smith, H. (1967). The effect of erythritol on the growth of
S19 and other attenuated strains of Brucella abortus. Res. Vet. Sci. 8, 294–296.
Khan, M. Y., Mah, M. W., and Memish, Z. A. (2001). Brucellosis in pregnant
women. Clin. Infect. Dis. 32, 1172–1177. doi: 10.1086/319758
Kim, S., Lee, D., Watanabe, K., Furuoka, H., Suzuki, H., and Watarai, M. (2005).
Interferon-γ promotes abortion due to Brucella infection in pregnant mice.
BMCMicrobiol. 5:22. doi: 10.1186/1471-2180-5-22
Köhler, S., Foulongne, V., Ouahrani-Bettache, S., Bourg, G., Teyssier, J., Ramuz, M.,
et al. (2002). The analysis of the intramacrophagic virulome of Brucella suis
deciphers the environment encountered by the pathogen inside the macrophage
host cell. Proc. Natl. Acad. Sci. U.S.A. 99, 15711–15716. doi: 10.1073/pnas.
232454299
Larose, J., Laflamme, J., Côté, I., Lapointe, J., Frenette, G., Sullivan, R., et al. (2012).
The polyol pathway in the bovine oviduct. Mol. Reprod. Dev. 79, 603–612.
doi: 10.1002/mrd.22067
Letesson, J.-J., Barbier, T., Zúñiga-Ripa, A., Godfroid, J., De Bolle, X., and
Moriyón, I. (2017). Brucella genital tropism: what’s on the menu. Front.
Microbiol. 8:506. doi: 10.3389/fmicb.2017.00506
Madore, E., Harvey, N., Parent, J., Chapdelaine, P., Arosh, J. A., and Fortier, M. A.
(2003). An aldose reductase with 20 -hydroxysteroid dehydrogenase activity is
most likely the enzyme responsible for the production of prostaglandin F2 in
the bovine endometrium. J. Biol. Chem. 278, 11205–11212. doi: 10.1074/jbc.
M208318200
McCullough, W. G., and Beal, G. A. (1951). Growth and manometric studies on
carbohydrate utilization of Brucella. J. Infect. Dis. 89, 266–271. doi: 10.1093/
infdis/89.3.266
Mol, J. P. S., Pires, S. F., Chapeaurouge, A. D., Perales, J., Santos, R. L., Andrade,
H. M., et al. (2016). Proteomic profile of Brucella abortus-infected bovine
chorioallantoic membrane explants. PLoS ONE 11:e0154209. doi: 10.1371/
journal.pone.0154209
Moreno, E., and Moriyón, I. (2006). “The genus Brucella,” in The Prokaryotes,
eds M. Dworkin, S. Falkow, E. Rosenberg, K.-H. Schleifer, and E. Stackebrandt
(New York, NY: Springer), doi: 10.1007/0-387-30745-1_17
Nataro, J. P. (2015). “Pathogenesis — Thoughts from the front line,” in Metabolism
and Bacterial Pathogenesis, eds T. Conway and P. S. Cohen (Washington, DC:
American Society of Microbiology), 17–26. doi: 10.1128/microbiolspec.MBP-
0012-2014
Navarro-Martinez, A., Solera, J., Corredoira, J., Beato, J. L., Martinez, A. E.,
Atienzar, M., et al. (2001). Epididymoorchitis due to Brucella melitensis: a
retrospective study of 59 patients. Clin. Infect. Dis. 33, 2017–2022. doi: 10.1086/
324489
Parent, M. A., Bellaire, B. H., Murphy, E. A., Roop, R. M., Elzer, P. H., and Baldwin,
C. L. (2012). Brucella abortus siderophore 2,3-dihydroxybenzoic acid (DHBA)
facilitates intracellular survival of the bacteria. Microb. Pathog. 32, 239–248.
doi: 10.1006/mpat.2002.0500
Pearce, J., Williams, A., Harris-Smith, P. W., Fitzgeorge, R., and Smith, H. (1962).
The chemical basis of the virulence of Brucella abortus: II. Erythritol, a
constituent of bovine foetal fluids which stimulates the growth of Br. abortus
in bovine phagocytes. Br. J. Exp. Pathol. 43, 31–37.
Pennington, K. A., Schlitt, J. M., and Schulz, L. C. (2012). Isolation of primary
mouse trophoblast cells and trophoblast invasion assay. J. Vis. Exp. 59:e3202.
doi: 10.3791/3202
Pruneda, A., Pinart, E., Bonet, S., Yeung, C.-H., and Cooper, T. G. (2006). Study of
the polyol pathway in the porcine epididymis. Mol. Reprod. Dev. 73, 859–865.
doi: 10.1002/mrd.20481
Ramana, K. V., and Srivastava, S. K. (2010). Aldose reductase: a novel therapeutic
target for inflammatory pathologies. Int. J. Biochem. Cell Biol. 42, 17–20.
doi: 10.1016/j.biocel.2009.09.009
Ratliff, D. M., Martinez, F. J., Vander Jagt, T. J., Schimandle, C. M., Robinson, B.,
Hunsaker, L. A., et al. (1999). Inhibition of human aldose and aldehyde
reductases by non-steroidal anti-inflammatory drugs. Adv. Exp. Med. Biol. 463,
493–499. doi: 10.1007/978-1-4615-4735-8_62
Regnault, T. R. H., Teng, C., de Vrijer, B., Galan, H. L., Wilkening, R. B., and
Battaglia, F. C. (2010). The tissue and plasma concentration of polyols and
sugars in sheep intrauterine growth retardation. Exp. Biol. Med. 235, 999–1006.
doi: 10.1258/ebm.2010.009360
Salcedo, S. P., Chevrier, N., Lacerda, T. L. S., Ben Amara, A., Gerart, S., Gorvel,
V. A., et al. (2013). Pathogenic brucellae replicate in human trophoblasts.
J. Infect. Dis. 207, 1075–1083. doi: 10.1093/infdis/jit007
Samartino, L. E., and Enright, F. M. (1993). Pathogenesis of abortion of bovine
brucellosis. Comp. Immunol. Microbiol. Infect. Dis. 16, 95–101. doi: 10.1016/
0147-9571(93)90001-L
Samartino, L. E., Traux, R. E., and Enright, F. M. (1994). Invasion and
replication of Brucella abortus in three different trophoblastic cell lines.
Zentralbl. Veterinarmed. B 41, 229–236. doi: 10.1111/j.1439-0450.1994.tb
00223.x
Sangari, F. J., Grilló, M. J., Jimenez de Bagues, M. P., González-Carreró, M. I.,
García-Lobo, J. M., Blasco, J. M., et al. (1998). The defect in the metabolism
of erythritol of the Brucella abortus B19 vaccine strain is unrelated with
its attenuated virulence in mice. Vaccine 16, 1640–1645. doi: 10.1016/S0264-
410X(98)00063-2
Smith, H., Williams, A., Pearce, E. J., Keppie, J., Harris-Smith, P. W., Fitz-
George, R. B., et al. (1962). Foetal erythritol: a cause of the localization of
Brucella abortus in bovine contagious abortion.Nature 193, 47–49. doi: 10.1038/
193047a0
Sperry, J. F., and Robertson, D. C. (1975). Inhibition of growth by erythritol
catabolism in Brucella abortus. J. Bacteriol. 124, 391–397.
Tawata, M., Ohtaka, M., Hosaka, Y., and Onaya, T. (1992). Aldose reductase
mRNA expression and its activity are induced by glucose in fetal rat aortic
smooth muscle (A10) cells. Life Sci. 51, 719–726. doi: 10.1016/0024-3205(92)
90480-D
Tobias, L., Cordes, D. O., and Schurig, G. G. (1993). Placental pathology of the
pregnant mouse inoculated with Brucella abortus strain 2308. Vet. Pathol. 30,
119–129. doi: 10.1177/030098589303000204
Vilchez, G., Espinoza, M., D’Onadio, G., Saona, P., and Gotuzzo, E. (2015).
Brucellosis in pregnancy: clinical aspects and obstetric outcomes. Int. J. Infect.
Dis. 38, 95–100. doi: 10.1016/j.ijid.2015.06.027
Williams, A. E., Keppie, J., and Smith, H. (1962). The chemical basis of the virulence
of Brucella abortus. III. Foetal erythritol a cause of the localisation of Brucella
abortus in pregnant cows. Br. J. Exp. Pathol. 43, 530–537.
Zinsstag, J., Schelling, E., Solera, J., Blasco, M. J., and Moriyón, I. (2011).
“Brucellosis,” in Handbook of Zoonoses, eds R. S. Palmer, L. Soulsby, R. P.
Torgeson, and G. D. Brown (Oxford: Oxford University Press), 54–62.
Zúñiga-Ripa, A., Barbier, T., Conde-Alvarez, R., Martínez-Gómez, E., Palacios-
Chaves, L., Gil-Ramírez, Y., et al. (2014). Brucella abortus depends on pyruvate
phosphate dikinase and malic enzyme but not on Fbp and GlpX fructose-
1,6-bisphosphatases for full virulence in laboratory models. J. Bacteriol. 196,
3045–3057. doi: 10.1128/JB.01663-14
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Barbier, Machelart, Zúñiga-Ripa, Plovier, Hougardy, Lobet,
Willemart, Muraille, De Bolle, Van Schaftingen, Moriyón and Letesson. This is an
open-access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) or licensor are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Microbiology | www.frontiersin.org 13 June 2017 | Volume 8 | Article 1088
